Waldén M, Dahlstrand C, Schäfer W, Pettersson S
Department of Urology, Sahlgrenska University Hospital, Göteborg, Sweden.
Br J Urol. 1998 Jun;81(6):817-22. doi: 10.1046/j.1464-410x.1998.00656.x.
To identify clinical variables useful in predicting outcome after transurethral microwave thermotherapy (TUMT) of the prostate with Prostasoft v. 2.0.
Thirty-eight men with symptomatic benign prostatic hyperplasia (BPH) were treated with TUMT using the Prostatron device with the low-energy (v. 2.0) software. Before and 6 months after treatment symptoms were evaluated using the Madsen-Iversen (M-I) symptom score, a clinical examination and suprapubic pressure-flow measurement, free urinary peak flow rate (Qmax) and determination of post-void residual urine volume (PVR). Bladder outlet obstruction was assessed from urodynamic pressure-flow studies using the classification of Abrams and Griffiths, the obstruction grading of Schäfer, and calculation of other published factors, e.g. the urethral resistance, an obstruction index and the detrusor adjusted mean passive urethral resistance factor (DAMPF). Categories of M-I score (total, irritative and obstructive), PVR and Qmax were investigated to determine whether any could predict the outcome after low-energy TUMT. The values after treatment and changes in Qmax, M-I score and PVR were used as efficacy variables.
Variables describing infravesical obstruction had predictive characteristics that may be useful in selecting patients for TUMT v. 2.0 and significantly better results were obtained in patients with a low to moderate obstruction as graded using the DAMPF classification of obstruction. The results also indicated that patients with a high irritative M-I score or a Qmax of 7-14 mL/s were those who fared best after TUMT.
Variables expressing the obstruction grade seem to be useful in predicting outcome after TUMT (v. 2.0). Patients with a high obstruction index are probably unsuitable for TUMT (v. 2.0).
确定在使用Prostasoft v. 2.0对前列腺进行经尿道微波热疗(TUMT)后,有助于预测治疗结果的临床变量。
38例有症状的良性前列腺增生(BPH)男性患者使用配备低能量(v. 2.0)软件的Prostatron设备接受TUMT治疗。治疗前及治疗后6个月,使用马德森 - 艾弗森(M - I)症状评分、临床检查及耻骨上压力 - 流率测量、自由尿流率峰值(Qmax)以及排尿后残余尿量(PVR)测定来评估症状。通过尿动力学压力 - 流率研究,采用艾布拉姆斯和格里菲斯分类法、舍费尔梗阻分级以及计算其他已发表的因素,如尿道阻力、梗阻指数和逼尿肌调整平均被动尿道阻力因子(DAMPF)来评估膀胱出口梗阻情况。研究M - I评分类别(总分、刺激性和梗阻性)、PVR和Qmax,以确定是否有任何一项能够预测低能量TUMT后的治疗结果。将治疗后的数值以及Qmax、M - I评分和PVR的变化用作疗效变量。
描述膀胱下梗阻的变量具有预测特征,这可能有助于为TUMT v. 2.0选择患者,并且按照DAMPF梗阻分类法分级为低至中度梗阻的患者取得了明显更好的治疗效果。结果还表明,刺激性M - I评分高或Qmax为7 - 14 mL/s的患者在TUMT后预后最佳。
表示梗阻分级的变量似乎有助于预测TUMT(v. 2.0)后的治疗结果。梗阻指数高的患者可能不适合TUMT(v. 2.0)。